1. Acknowledgement to Referees

   Acknowledgement to Referees 02 November 2021 Pages: 589 - 592

2. Targeted Therapy for Primary Sjögren’s Syndrome: Where are We Now?

   • Bin Wang
   • Shiju Chen
   • Guixiu Shi

   Leading Article 03 November 2021 Pages: 593 - 610

   

3. Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review

   • Win Min Oo
   • David J Hunter

   Leading Article 22 November 2021 Pages: 611 - 641

   

4. Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy

   • Andrea L. J. Marschall

   Review Article Open access 27 October 2021 Pages: 643 - 671

   

5. Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update

   • Mariacristina Parravano
   • Eliana Costanzo
   • Gianni Virgili

   Review Article 16 October 2021 Pages: 673 - 692

6. Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design

   • Araceli Rivera-Ordaz
   • Valeria Peli
   • Lorenza Lazzari

   Review Article Open access 02 November 2021 Pages: 693 - 714

   

7. Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

   • Steven J. Bots
   • Claire E. Parker
   • Niels Vande Casteele

   Systematic Review 19 November 2021 Pages: 715 - 733

   

8. Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

   • Steven R. Feldman
   • Nataliya Reznichenko
   • Heimo Stroissnig

   Original Research Article Open access 16 October 2021 Pages: 735 - 748

   

9. Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project

   • Gianluca Trifirò
   • Valentina Isgrò
   • VALORE Project Collaborators

   Original Research Article Open access 12 October 2021 Pages: 749 - 764

   

10. Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept

    • Rosanne W. Meijboom
    • Helga Gardarsdottir
    • Thijs J. Giezen

    Original Research Article Open access 26 October 2021 Pages: 765 - 772